My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

ADC Therapeutics SA Common Shares (NY:ADCT)

4.100 -0.120 (-2.84%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ADC Therapeutics SA Common Shares

< Previous 1 2 3 4 Next >

Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022 ↗

November 09, 2022

Upgrades

Via Benzinga

Analyst Ratings for ADC Therapeutics ↗

November 09, 2022

Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

Analyst Ratings for ADC Therapeutics ↗

September 09, 2022

Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:

Via Benzinga

Expert Ratings for ADC Therapeutics ↗

September 09, 2022

ADC Therapeutics (NYSE:ADCT) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

Where ADC Therapeutics Stands With Analysts ↗

September 09, 2022

Over the past 3 months, 4 analysts have published their opinion on ADC Therapeutics (NYSE:ADCT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday ↗

August 22, 2022

Via Benzinga

ADC Therapeutics: Q2 Earnings Insights ↗

August 09, 2022

ADC Therapeutics (NYSE:ADCT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug ↗

July 08, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Analyst Ratings for ADC Therapeutics ↗

May 10, 2022

Analysts have provided the following ratings for ADC Therapeutics (NYSE:ADCT) within the last quarter:

Via Benzinga

ADC Therapeutics: Q1 Earnings Insights ↗

May 09, 2022

ADC Therapeutics (NYSE:ADCT) reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Outlook For ADC Therapeutics ↗

August 08, 2022

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that ADC...

Via Benzinga

Why ADC Therapeutics Shares Are Rising Today ↗

July 08, 2022

ADC Therapeutics SA (NYSE: ADCT) shares are trading higher by 11.56% to $10.23 Friday afternoon after the company entered into an exclusive license agreement with Swedish Orphan Biovitrum for the...

Via Benzinga

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications ↗

June 13, 2022

Via Benzinga

RBC Capital Maintains Outperform Rating for ADC Therapeutics: Here's What You Need To Know ↗

May 10, 2022

RBC Capital has decided to maintain its Outperform rating of ADC Therapeutics (NYSE:ADCT) and lower its price target from $34.00 to $30.00. Shares of ADC Therapeutics are trading down 1.34% over the...

Via Benzinga

Recap: ADC Therapeutics Q4 Earnings ↗

March 03, 2022

ADC Therapeutics (NYSE:ADCT) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 10, 2022

Gainers

Via Benzinga

Mid-Afternoon Market Update: Crude Oil Down 6%; Palantir Technologies Shares Slide ↗

May 09, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Monday.

Via Benzinga

Mid-Day Market Update: Nasdaq Dips 450 Points; Hemisphere Media Group Shares Surge ↗

May 09, 2022

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping around 450 points on Monday.

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

May 09, 2022

Gainers

Via Benzinga

Earnings Outlook For ADC Therapeutics ↗

May 06, 2022

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that ADC...

Via Benzinga

How To Attend ADC Therapeutics Q1 2022 Earnings Conference Call ↗

May 04, 2022

ADC Therapeutics (NYSE:ADCT) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend ADC Therapeutics (ADCT) Conference Call Follow this link to...

Via Benzinga

Cantor Fitzgerald Cuts ADC Therapeutics Price Target On 'Repositioned Zynlonta Pipeline Strategy' ↗

March 04, 2022

Following Q4 FY21 results, Cantor Fitzgerald has lowered the price target on ADC Therapeutics SA (NASDAQ: ADCT) to $26 from $45 and keeps an Overweight rating...

Via Benzinga

Earnings Preview For ADC Therapeutics ↗

March 02, 2022

ADC Therapeutics (NYSE:ADCT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

ADC Therapeutics, Mitsubishi Tanabe Ink Zynlonta Licensing Pact In Japan ↗

January 18, 2022

ADC Therapeutics SA (NYSE: ADCT) has entered an exclusive license agreement with Mitsubishi Tanabe Pharma Corporation to develop and commercialize...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.